32 months, p = 0.10); nevertheless, there was a favorable trend in the conventional group for patients with bilobar neoplasia, portal hypertension, and elevated AFP [ 70 ].
← all excerpts
In the Era of Systemic Therapy for Hepatocellular Carcinoma Is Transarterial Chemoembolization Still a Card to Play?
1
—
—